| Serial Number | 98308022 |
| Word Mark | NOVARTIS |
| Filing Date | Monday, December 11, 2023 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Wednesday, January 7, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 14, 2024 |
| Goods and Services | Downloadable software for the facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; downloadable software in the nature of a mobile application for facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields |
| Goods and Services | Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosis, prevention and treatment of haematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of kidney diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diabetes; medical apparatus and instruments for the diagnosis, prevention and treatment of hypertension; medical apparatus and instruments for the diagnosis, prevention and treatment of skin disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of urinary diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of ophthalmological diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of cancer and tumors; medical apparatus and instruments for the diagnosis, prevention and treatment of allergies; medical apparatus and instruments for the diagnosis, prevention and treatment of bone diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical use; genetic testing apparatus and instruments for medical use; electromagnetic drug delivery apparatus and instruments for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical use; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for introducing pharmaceutical preparations into the human body |
| Description of Mark | The mark consists of a stylized presentation of a mortar and pestle to the left of the stylized word "NOVARTIS". The mortar is depicted in orange and yellow, with the top left of the mortar in orange and transitioning to yellow in a counter-clockwise direction. The pestle is shown in blue. The word "NOVARTIS" is presented in capital letters in blue. |
| Indication of Colors claimed | The color(s) orange, yellow and blue is/are claimed as a feature of the mark. |
| Goods and Services | Providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 11, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 11, 2023 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 11, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Basel 4002 CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4002 CH |
| Event Date | Event Description |
| Monday, December 11, 2023 | NEW APPLICATION ENTERED |
| Tuesday, March 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 12, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, March 20, 2024 | ASSIGNED TO EXAMINER |
| Monday, April 8, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, April 8, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, April 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 9, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, April 9, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 9, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 9, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, April 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 14, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 14, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 9, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 7, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 7, 2025 | SOU EXTENSION 1 FILED |
| Tuesday, January 7, 2025 | SOU EXTENSION 1 GRANTED |
| Tuesday, January 7, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 1, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 1, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |
| Tuesday, December 30, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, July 1, 2025 | DIVISIONAL REQUEST RECEIVED |
| Wednesday, December 31, 2025 | DIVISIONAL PROCESSING COMPLETE |
| Monday, June 30, 2025 | SOU EXTENSION 2 FILED |
| Wednesday, December 31, 2025 | SOU EXTENSION 2 GRANTED |
| Wednesday, December 31, 2025 | CORRECTED NOA E-MAILED |
| Thursday, January 1, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, January 6, 2026 | SOU TEAS EXTENSION RECEIVED |
| Monday, January 5, 2026 | SOU EXTENSION 3 FILED |
| Wednesday, January 7, 2026 | SOU EXTENSION 3 GRANTED |
| Thursday, January 8, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |